ProShares Ultra Nasdaq Biotechnology ETF (BIB) Earning Somewhat Positive Media Coverage, Study Shows - Week Herald
Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ProShares Ultra Nasdaq Biotechnology ETF earned a news impact score of 0.12 on Accern's scale. Accern ...
Somewhat Favorable News Coverage Somewhat Unlikely to Impact ProShares Ultra Nasdaq Biotechnology ETF (BIB ... - TrueBlueTribune
ProShares Ultra Nasdaq Biotechnology ETF earned a news sentiment score of 0.20 on Accern's scale. Accern also assigned media stories about the exchange traded fund an impact score of 46.6734154688987 out of 100, meaning that recent media ...altro »
Ultra Nasdaq Biotech Proshares (BIB): Technicals in Focus - The Business Union
Tracking shares of Ultra Nasdaq Biotech Proshares (BIB), we have noted that Span A is presently above Span B. Traders following this signal will be looking for signs of a bullish stock price shift. Active traders have a wide variety of technical ...
Somewhat Positive Media Coverage Somewhat Unlikely to Affect ProShares Ultra Nasdaq Biotechnology ETF (BIB ... - The Ledger Gazette
ProShares Ultra Nasdaq Biotechnology ETF earned a media sentiment score of 0.07 on Accern's scale. Accern also gave media stories about the exchange traded fund an impact score of 45.3053805810339 out of 100, meaning that recent press coverage is ...
ProShares Ultra Nasdaq Biotechnology ETF - Receive News & Ratings Daily - Weekly Register
Oct 5 is a positive day so far for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) as the ETF is active during the day after gaining 0.38% to hit $63.95 per share. The exchange traded fund has 506.49M net assets and 4.41% volatility this month. Over ...
ProShares UltraShort Nasdaq Biotech (BIS) Rises 0.55% for Oct 11 - KL Daily
Over the course of the day 17,903 shares traded hands, as compared to an average volume of 427,580 over the last 30 days for ProShares UltraShort Nasdaq Biotech (NASDAQ:BIS). The ETF is -44.08% of its 52-Week High and 8.40% of its low, and is ...altro »
Biotechs Beating The Market, But Are They In Buy Range? - Nasdaq
Biotechs continue to outmuscle the broader stock market as both nonleveraged and leveraged exchange traded funds are showing healthy gains. [ibd-display-video id=2323711 width=50 float=left autostart=true]Despite a recent pullback, iShares Nasdaq ...altro »
Big Dose Of Healthy News Sends Biotech Stocks To New Heights - Nasdaq
ProShares Ultra Nasdaq Biotechnology (BIB), which aims for twice the return of the Nasdaq Biotechnology Index, has generated big returns this year. The $479.8 million fund has rallied 50.7% year to date. Shares have eased 2% off their 52-week high.altro »
Trading Monitor: What's Next For Ultra Nasdaq Biotech Proshares (BIB)? - Baxter Review (blog)
Traders have been keeping a close eye on shares of Ultra Nasdaq Biotech Proshares (BIB). Currently, the company has a 14-day RSI of 62.64, the 7-day is 63.44, and the 3-day is resting at 69.85.The Relative Strength Index (RSI) is one of multiple ...
Evaluating the Biotech ETF Rally - ETF Trends
ETF traders who are betting big on the biotechnology sector rebound have also utilized leveraged long options including the Direxion Daily S&P Biotech Bull Shares (NYSEArca: LABU), which takes the 3x or 300% daily performance of the S&P Biotechnology ...altro »